Human Anti-OPGL Neutralizing Antibodies as Selective OPGL, Pathway Inhibitors

Details for Australian Patent Application No. 2011265413 (hide)

Owner Amgen Inc. Medarex, Inc.

Inventors Boyle, William James; Sullivan, John Kevin; Medlock, Eugene; Elliott, Robin L.; Martin, Frank; Huang, Haichun

Agent Wrays

Pub. Number AU-A-2011265413

Parent 2007202619

Filing date 21 December 2011

Wipo publication date 19 January 2012

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 19/08 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

19 January 2012 Application Open to Public Inspection

  Published as AU-A-2011265413

19 January 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011265414-Compositions and methods relating to novel compounds and targets thereof

2011265412-Electronic device for digital object management